The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Heplisav-B
Hepatitis B Vaccine (Recombinant) Adjuvanted · HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN 20 ug/.5mL · Injection, Solution · Intramuscular · Bamboo US BidCo LLC
NDC 83703-0048-05 · 5 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE · BLA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $157.13 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BLA125428
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Hepatitis B Vaccine (Recombinant) Adjuvanted (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN 20 ug/.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Bamboo US BidCo LLC | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN 20 ug/.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Dynavax Technologies Corporation | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN 20 ug/.5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Heplisav-B — NDC 83703-0048-05," retrieved September 3, 2026, https://drugdashboards.com/drug/83703004805.
Free to cite with attribution — see how the data is put together.